Rhinitis: A practical and comprehensive approach to assessment and therapy

Journal of Otolaryngology

Volumn 36, Issue SUPPL. 1, 2007, Pages

  Small, Peter ^a,o   Frenkiel, Saul ^a   Becker, Allan ^b   Boisvert, Pierre ^c   Bouchard, Jacques ^d   Carr, Stuart ^e   Cockcroft, Don ^f   Denburg, Judah ^g   Desrosiers, Martin ^a,h   Gall, Richard ^b   Hamid, Qutayba ^a   Hébert, Jacques ^c   Javer, Amin ⁱ   Keith, Paul ^g   Kim, Harold ^g   Lavigne, François ^h   Lemière, Catherine ^h   Massoud, Emad ^j   Payton, Keith ^k   Schellenberg, Bob ⁱ   Sussman, Gordon ^l   Tannenbaum, David ^m   Watson, Wade ^j   Witterick, Ian ^m   Wright, Erin ⁿ   more..

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f ROYAL UNIVERSITY HOSPITAL   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ ST PAUL S HOSPITAL   (Canada)

^j DALHOUSIE UNIVERSITY   (Canada)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^o MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Allergic rhinitis; Rhinitis; Upper airway

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDESONIDE; CHLORPHENIRAMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESLORATADINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCABASTINE; LORATADINE; LUBRICATING AGENT; MOMETASONE FUROATE; MONTELUKAST; OLIGODEOXYNUCLEOTIDE; PREDNISONE; PSEUDOEPHEDRINE; TRIAMCINOLONE; UNINDEXED DRUG; ZAFIRLUKAST;

ALLERGIC RHINITIS; CANADA; CHILD GROWTH; CONSENSUS DEVELOPMENT; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; GROWTH INHIBITION; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; IRRITABILITY; LIVER FAILURE; MEDICAL SPECIALIST; NIGHTMARE; NOSE IRRITATION; PRIORITY JOURNAL; REVIEW; RHINITIS; SIDE EFFECT; TREATMENT PLANNING;

EID: 34347220818     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2006.X002     Document Type: Review

References (134)

1. Assessing and treating rhinitis. A practical guide for Canadian physicians. Proceedings of the Canadian Rhinitis Symposium. Toronto, Ontario, Canada. January 14-15, 1994. CMAJ 1994;151(4 Suppl): 1-27.
2. Bousquet J, van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-334.
3. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108:S2-8.
4. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989;19:59-63.
5. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998;2:3-10.
6. Sakurai Y, Nakamura K, Teruya K, et al. Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men. Prev Med 1998;27:617-22.
7. Bridger GP. Physiology of the nasal valve. Arch Otolaryngol 1970;92:543-53.
8. Haight JJ, Cole P. Reciprocating nasal airflow resistances. Acta Otolaryngol (Stockh) 1984;97:93-8.
9. Stoksted P. Rhinometric measurements for determination of the nasal cycle. Acta Otolaryngol Suppl (Stockh) 1953;109:159-75.
10. Ingelstedt S, Toremulum N. Airflow patterns and heat transfer within the respiratory tract. Acta Physiol Scand 1961;51:204-17.
11. Drake-Lee A. Physiology of the nose and paranasal sinuses. In: Wright D, editor. Scott-Brown's otolaryngology. London: Butterworth & Co.; 1987. p. 162-82.
12. Eccles R, Bende M, Widdicombe J. Nasal blood vessels. In: Mygind N, Pipkorn U, editors. Allergic and vasomotor rhinitis: pathophysiological aspects. Copenhagen: Munksgaard; 1987.
13. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979;120:1325-73.
14. Celedon J, Palmer L, Weiss S, et al. Asthma, rhinitis, and skin test reactivitiy to aeroallergens in families of asthmatic subjects in Anqing, China. Am J Respir Crit Care Med 2001;163:1108-12.
15. Weille FL. Studies in asthma XIX. The nose and throat in five hundred cases of asthma. N Engl J Med 1936;215:235-9.
16. Pedersen P, Weeke E. Asthma and allergic rhinitis in the same patients. Allergy 1983;38:25-9.
17. Greisner W, Settipane R, Settipane G. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998; 19:185-8.
18. Kapsali T, Horowitz E, Togias A. Rhinitis is ubiquitous in allergic asthmatics [abstract]. J Allergy Clin Immunol 1997;99:S138.
19. Horowitz E, Diemer FB, Poyser J, et al. Asthma and rhinosinusitis prevalance in a Baltimore city public housing complex [abstract]. J Allergy Clin Immunol 2001;107:S280.
20. Guerra S, Sherrill D, Martinez F, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-25.
21. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104(2 Pt 1):301-4.
22. Chakir J, Laviolette M, Turcotte H, et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000;106:904-10.
23. Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30:663-9.
24. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402(6760 Suppl):B2-4.
25. Simons FER. What's in a name? The allergic rhinitis-asthma connection. Clin Exp Allergy Res 2003;3:9-17.
26. Togias A. Functional relationships between allergic rhinitis and asthma. Clin Exp Allergy Res 2003; 3:18-22.
27. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-83.
28. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82: 233-48.
29. Sobol SE, Frenkiel S, Nachtigal D, et al. Clinical manifestations of sinonasal pathology during pregnancy. J Otolaryngol 2001;30:24-8.
30. Glasier CM, Ascher DP, Williams KD. Incidental paranasal sinus abnormalities on CT of children: clinical correlation. AJNR Am J Neuroradiol 1986; 7:861-4.
31. Zinreich SJ. Rhinosinusitis: radiographic diagnosis. Otolaryngol Head Neck Surg 1997;117(3 Pt. 2):S27-34.
32. Bousquet J, Lund VJ, van Cauwenberge P, et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003;58:733-41.
33. Solomon WR, Burge HA, Boise JR. Exclusion of particulate allergens by window air conditioners. J Allergy Clin Immunol 1980;65:305-9.
34. Frederick JM, Warner JO, Jessop WJ, et al. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 1997;10:361-6.
35. Arlian L, Neal JS, Morgan MS, et al. Reducing relative humidity is a practical way to control dust mites and their allergens in homes in temperate climates. J Allergy Clin Immunol 2001;107:99-104.
36. McDonald LG, Tovey E. The role of water temperature and laundry procedures in reducing house dust mite populations and allergen content of bedding. J Allergy Clin Immunol 1992;90(4 Pt 1):599-608.
37. Kalra S, Owen SJ, Hepworth J, et al. Airborne house dust mite antigen after vacuum cleaning. Lancet 1990;336:449.
38. Apter AJ. Early exposure to allergen: is this the cat's meow, or are we barking up the wrong tree? J Allergy Clin Immunol 2003;111:938-46.
39. Almqvist C, Egmar AC, van Hage-Hamsten M, et al. Heredity, pet ownership, and confounding control in a population-based birth cohort. J Allergy Clin Immunol 2003;111:800-6.
40. Ronmark E, Perzanowski M, Platts-Mills T, et al. Four-year incidence of allergic sensitization among school-children in a community where allergy to cat and dog dominates sensitization: report from the Obstructive Lung Disease in Northern Sweden Study Group. J Allergy Clin Immunol 2003;112:747-54.
41. Lau S, Wahn U. Pets - good or bad for individuals with atopic predisposition? J Allergy Clin Immunol 2003;112:263-4.
42. Svanes C, Heinrich J, Jarvis D, et al. Pet-keeping in childhood and adult asthma and hay fever: European Community Respiratory Llealrh Survey. J Allergy Clin Immunol 2003;112:289-300.
43. de Meer G, Toelle BG, Ng K, et al. Presence and timing of cat ownership by age 18 and the effect on atopy and asthma at age 28. T Allergy Clin Immunol 2004; 113:433-8.
44. Kaliner M, Lenianske R. Rhinitis and asthma. JAMA 1992;268:2807-29.
45. De Blay R, Chapman MD, Platts-Mills T. Airborne cat allergen (Fel dl): environmental control with the cat in situ. Am Rev Respir Dis 1991;143:1334-9.
46. Glinert R, Wilson P, Wedner HJ. Fel dl is markedly reduced following sequential washings of cats (abstract). J Allergy Clin Immunol 1990;85:225.
47. Nageris B, Braverman I, Hadar T, et al. Effects of passive smoking on odour identification in children. J Otolaryngol 2001;30:263-5.
48. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 2000;132:354-63.
49. Simons FER. Allergic rhinitis: recent advances. Paediatr Clin North Am 1988;35:1053-74.
50. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002; 109:636-42.
51. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis patients with comorbid asthma: the risk of emergency department visits. J Allergy Clin Immunol 2002;109:57-62.
52. Aaronson DW. Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996;76:440-6.
53. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95(5 Pt 1):923-32.
54. Warner JO, ETAC Study Group. Early treatment of the atopic child. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108:929-37.
55. Pipkorn U, Proud D, Lichtenstein LM, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316:1506-10.
56. Andersson M, Andersson P, Pipkom U. Topical glucocorticoids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988;82:1019-26.
57. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002;89:479-84.
58. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 2004;116:338-44.
59. Pullerits T, Praks L, Ristioja V, et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:949-55.
60. Watson WT, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway hyperresponsiveness. J Allergy Clin Immunol 1993; 91(1 Pt 1):97-101.
61. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002; 109:636-42.
62. Meltzer EO, Charous BL, Busse WW, et al. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol 2000;106:630-7.
63. Parikh A, Scadding GK, Darby Y, et al. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001;39:75-9.
64. Dolor RJ, Witsell DL, Hellkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 2001;286:3097-105.
65. Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002;89:271-8.
66. DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 2003;24:331-7.
67. Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004;34:952-7.
68. Allen DB. Systemic effects of intranasal corticosteroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000;106(4 Suppl):S179-90.
69. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23.
70. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064-9.
71. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000; 105(2):E22.
72. Allen DB, Meltzer EO, Lemanske RF Jr, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002;23:407-13.
73. Lipworth BJ. Emerging role of antileukotriene therapy in allergic rhinitis. Clin Exp Allergy 2001;31:1813-21.
74. Ratner PH, Howland WC III, Arastu R, et al. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol 2003;90:536-42.
75. Wilson AM, Orr LC, Sims EJ, et al. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001;31:61-8.
76. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004;34:259-67.
77. Weinstein SF, LaForce CF, Ratner PH, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin E;xp Allergy 2002; 32:1020-8.
78. Dahlen B, Roquet A, Inman MD, et al. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol 2002;109:789-93.
79. Ragab S, Parikh A, Darby YC, et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001;31:1385-91.
80. Korenblat PE, Antileukotriene Working Group. The role of antileukotrienes in the treatment of asthma. Ann Allergy Asthma Immunol 2001;86(6 Suppl 1):31-9.
81. Reinus JF, Persky S, Burkiewicz JS, et al. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med 2000;133:964-8.
82. Sohoel P, Freng BA, Kramer J, et al. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis. J Allergy Clin Immunol 1993;92(1 Pt 1):73-81.
83. Borum P, Mygind N, Schultz-Larsen F. Intranasal ipratropium: a new treatment for perennial rhinitis. Clin Otolaryngol 1979;4:407-11.
84. Dolovich J, Kennedy L, Vickerson F, et al. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide. J Allergy Clin Immunol 1987;80(3 Pt 1):274-8.
85. Brown JL, Frew AJ. The efficacy of oromucosal immunotherapy in respiratory allergy. Clin Exp Allergy 2001;31:8-10.
86. Frew AJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001;107:441-4.
87. Westritschnig K, Valenta R. Can we genetically engineer safer and more effective immunotherapy reagents? Curr Opin Allergy Clin Immunol 2003;3:495-500.
88. Alexander C, Kay AB, Larche M. Peptide-based vaccines in the treatment of specific allergy. Curr Drug Targets Inflamm Allergy 2002;1:353-61.
89. Creticos P, Eiden JJ, Broide DH, et al. Immunotherapy with immunostimulatory oligonucleotides linked to purified ragweed Amb a 1 allergen: effects on antibody production, nasal allergen provocation, and ragweed seasonal rhinitis [abstract]. J Allergy Clin Immunol 2002;109:743-4.
90. Soler M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254-61.
91. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90.
92. Corren J, Casale T, Deniz Y, et al. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol 2003;111:87-90.
93. Milgrom H, Fick RB Jr, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999; 341:1966-73.
94. Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001;108(2):E36.
95. Wenzel S, Bousquet J, Holgate S, et al. Factors predictive of response to omalizumab therapy in patients with moderate-to-severe allergic asthma [abstract]. J Allergy Clin Immunol 2002;109:A458.
96. Holgate S, Bousquet J, Wenzel S, et al. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortalitv. Curr Med Res Opin 2001;17:233-40.
97. Ayres JG, Higgins B, Chilvers ER, et al. Omalizumab reduces the risk of asthma deterioration-related incidents in patients with poorly controlled allergic asthma [abstract]. J Allergy Clin Immunol 2003;111:A534.
98. Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709-17.
99. Scadding GK, Lund VJ, Darby YC, et al. IgG subclass levels in chronic rhinosinusitis. Rhinology 1994; 32:15-9.
100. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-13.
101. Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005;60:875-81.
102. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf 1999;20:361-75.
103. Einarson A, Bailey B, Jung G, et al. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997;78:183-6.
104. Ellegard EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001;26:394-400.
105. Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol 1978;61:268-72.
106. Shaikh WA. A retrospective study on the safety of immunotherapy in pregnancy. Clin Exp Allergy 1993;23:857-60.
107. Settipane RA, Chafee FH, Settipane GA. Pollen immunotherapy during pregnancy: long-term follow-up of offsprings. Allergy Proc 1988;9:555-61.
108. Chang CW, Ries WR. Surgical treatment of the inferior turbinate: new techniques. Curr Opin Otolaryngol Head Neck Surg 2004;12:53-7.
109. Hartley C, Willatt DJ. Cryotherapy in the treatment of nasal obstruction: indications in adults. J Laryngol Otol 1995;109:729-32.
110. Williamson IG, Timms M, Canty P. A new cryoprobe with advantages in turbinate freezing. J Laryngol Otol 1988;102:503-5.
111. Bumsted RM. Cryotherapy for chronic vasomotor rhinitis: technique and patient selection for improved results. Laryngoscope 1984;94:539-44.
112. Moore JR, Bicknell PG. A comparison of cryosurgery and submucous diathermy in vasomotor rhinitis. J Laryngol Otol 1980;94:1411-3.
113. Principato JJ. Chronic vasomotor rhinitis: cryogenic and other surgical modes of treatment. Laryngoscope 1979;89:619-38.
114. Puhakka H, Rantanen T. Cryotherapy as a method of treatment in allergic and vasomotor rhinitis. J Laryngol Otol 1977;91:535-9.
115. Molony TJ. Cryosurgery in chronic nasal obstruction. J Otolaryngol 1976;5:156-8.
116. Fradis M, Malatskey S, Magamsa I, et al. Effect of submucosal diathermy in chronic nasal obstruction due to turbinate enlargement. Am J Otolaryngol 2002;23:332-6.
117. Olu Ibekwe A. The value of electrocautery to the inferior turbinates in the treatment of chronic rhinitis. Trop Geogr Med 1989;41:169-71.
118. Talaat M, el-Sabawy E, Baky FA, et al. Submucous diathermy of the inferior turbinates in chronic hypertrophic rhinitis. J Laryngol Otol 1987;101:452-60.
119. Jones AS, Lancer JM, Moir AA, et al. The effect of submucosal diathermy to the inferior turbinates on nasal resistance to airflow in allergic and vasomotor rhinitis. Clin Otolaryngol 1985;10:249-52.
120. von Haacke NP, Hardcastle PF. Submucosal diathermy of the inferior turbinate and the congested nose. ORL J Otorhinolaryngol Relat Spec 1985;47:189-93.
121. Quine SM, Aitken PM, Eccles R. Effect of submucosal diathermy to the inferior turbinates on unilateral and total nasal airflow in patients with rhinitis. Acta Otolaryngol (Stockh) 1999;119:911-5.
122. Ito H, Baba S, Suzuki M, et al. Severe perennial allergic rhinitis treated with Nd:YAG laser. Acta Otolaryngol Suppl (Stockh) 1996;525:14-7.
123. Lippert BM, Werner JA. Long-term results after laser turbinectomy. Lasers Surg Med 1998;22:126-34.
124. Lagerholm S, Harsten G, Emgard P, et al. Laser-turbinectomy: long-term results. J Laryngol Otol 1999; 113:529-31.
125. Inouye T, Tanabe T, Nakanoboh M, et al. Laser surgery for allergic and hypertrophic rhinitis. Ann Otol Rhinol Laryngol Suppl 1999;180:3-19.
126. Janda P, Sroka R, Tauber S, et al. Diode laser treatment of hyperplastic inferior nasal turbinates. Lasers Surg Med 2000;27:129-39.
127. Wexler DB, Berger G, Derowe A, et al. Long-term histologic effects of inferior turbinate laser surgery. Otolaryngol Head Neck Surg 2001;124:459-63.
128. Lin HC, Lin PW, Su CY, et al. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy. Laryngoscope 2003;113:673-8.
129. Seeger J, Zenev E, Gundlach P, et al. Bipolar radiofrequency-induced thermotherapy of turbinate hypertrophy: pilot study and 20 months' follow-up. Laryngoscope 2003;113:130-5.
130. Back LJ, Hytonen ML, Malmberg HO, et al. Submucosal bipolar radiofrequency thermal ablation of inferior turbinates: a long-term follow-up with subjective and objective assessment. Laryngoscope 2002;112:1806-12.
131. Elwany S, Gaimaee R, Fattah HA. Radiofrequency bipolar submucosal diathermy of the inferior turbinates. Am J Rhinol 1999;13:145-9.
132. Mabry RL. "How I do it" - plastic surgery. Practical suggestions on facial plastic surgery. Inferior turbinoplasty. Laryngoscope 1982;92:459-61.
133. Eliashar R. Total inferior turbinectomy: operative results and technique. Ann Otol Rhinol Laryngol 2001;110(7Pt 1):700.
134. Clement WA, White PS. Trends in turbinate surgery literature: a 35-year review. Clin Otolaryngol 2001; 26:124-8.